The PACS and RIS Market Is Expected to Witness the Most Promising Growth Opportunities in Asia Pacific over the Report's Forecast Period
On the basis of product type, the global PACS and RIS market witnessed the emergence of PACS as the leading segment in terms of revenue in 2015. The widespread use of PACS and the continuously rising demand across the cardiology and orthopedics sectors are expected to help PACS retain its dominance over the forecast period as well. Of the variety of types of PACS products available in the global market, the segment of oncology PACS is expected to be the...
View full press release